Daihan Pharmaceutical Co., Ltd. (023910)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
25,550. 00
-400
-1.5414%
₩
170.23B Market Cap
- P/E Ratio
3,600% Div Yield
5,730 Volume
- Eps
₩ 25,950
Previous Close Want to track 023910 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Daihan Pharmaceutical Co., Ltd. (023910) Statistics
Valuation metrics
Market Cap 170.23B
Enterprise value 92.45B
Trailing P/E (ttm) 5.52
Forward P/E -
PEG ratio -0.46
Price/Sales (ttm) 0.7
Price/Book (mrq) 0.49
Enterprise Value/Revenue 0.43
Enterprise Value/EBITDA 2.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.33K
Average volume (90 days) 6.76K
Price summary
52-Week low 24,000
52-Week high 31,650
Beta -
50-Day moving average 26,495.31
200-Day moving average 26,940.3
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 900
Trailing annual dividend yield 0.0348%
5-Year annual dividend yield -
Payout ratio 0.21
Dividend Date 17 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 10:1
Last split Date 29 Apr 2002
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 36,828.9
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4,681.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 19,514.47
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 3.97%
Book value per share (mrq) 52,392.43
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
